SAN DIEGO, Jan. 8, 2009 (GLOBE NEWSWIRE) -- Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced that Jonathan Lim, M.D., Halozyme’s President and CEO, will present at the J.P. Morgan 27th Annual Healthcare Conference on Thursday, January 15, 2009 at 1:30 p.m. PST (4:30 p.m. EST) at the Westin St. Francis Hotel in San Francisco.
